Variant report
Variant | nsv522521 |
---|---|
Chromosome Location | chr5:12163379-12174985 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:12165801..12168433-chr5:12169340..12171868,2 | MCF-7 | breast: | |
2 | chr5:12165801..12168433-chr5:12169340..12171868,2 | MCF-7 | breast: | |
3 | chr5:12174934..12177905-chr5:12178923..12181158,2 | MCF-7 | breast: | |
4 | chr5:12163951..12166758-chr5:12177328..12180114,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544348752 | chr5:12170025-12170026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369450905 | chr5:12170053-12170054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576286782 | chr5:12170063-12170064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73744298 | chr5:12170161-12170162 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs561915943 | chr5:12170193-12170194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529423042 | chr5:12170196-12170197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139909136 | chr5:12170241-12170242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs180778662 | chr5:12170245-12170246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563013444 | chr5:12170291-12170292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533299754 | chr5:12170343-12170344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527293410 | chr5:12170379-12170380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552112954 | chr5:12170411-12170412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368342022 | chr5:12170431-12170432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570775896 | chr5:12170447-12170448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143418870 | chr5:12170464-12170465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs372037757 | chr5:12170465-12170466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34807623 | chr5:12170475-12170476 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs550077803 | chr5:12170540-12170541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10474680 | chr5:12170561-12170562 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs5865991 | chr5:12172406-12172407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75384175 | chr5:12172407-12172408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561638271 | chr5:12172442-12172443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143208393 | chr5:12172502-12172503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552391669 | chr5:12172510-12172511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370568904 | chr5:12172514-12172515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541348196 | chr5:12172611-12172612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs190838274 | chr5:12172627-12172628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147076693 | chr5:12172656-12172657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35170305 | chr5:12172683-12172684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533157794 | chr5:12172698-12172699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551123272 | chr5:12172706-12172707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs16902057 | chr5:12172728-12172729 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs530887556 | chr5:12172852-12172853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549044513 | chr5:12172856-12172857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567686229 | chr5:12172880-12172881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528467655 | chr5:12172929-12172930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547317468 | chr5:12172936-12172937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571799920 | chr5:12172986-12172987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182649687 | chr5:12172991-12172992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs138485047 | chr5:12173032-12173033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569788520 | chr5:12173127-12173128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537169179 | chr5:12173183-12173184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555151722 | chr5:12173196-12173197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573620837 | chr5:12173201-12173202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs373528677 | chr5:12173215-12173216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144061724 | chr5:12173224-12173225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553243452 | chr5:12173244-12173245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188794140 | chr5:12173263-12173264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs193250722 | chr5:12173297-12173298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563172777 | chr5:12173362-12173363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cervical squamous cell carcinoma | 21590768 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cri-du chat syndrome | 16773131 | CNVD |
Cryptorchidism | 21048976 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cervical cancer | 16585170 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cri-du chat syndrome | 22470819 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 18940311 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Mental retardation | 17847001 | CNVD |
Neurocytoma | 17123091 | CNVD |
Mental retardation | 19546859 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:12170000-12170600 | Enhancers | Fetal Brain Female | brain |
2 | chr5:12172400-12172600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr5:12172400-12176800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr5:12172600-12174400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr5:12173400-12173600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr5:12173600-12175000 | Enhancers | H9 Cell Line | embryonic stem cell |
7 | chr5:12173600-12175600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr5:12173600-12176600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr5:12173600-12177000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr5:12174000-12174200 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
11 | chr5:12174000-12175600 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr5:12174000-12176400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr5:12174000-12177000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr5:12174200-12176200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
15 | chr5:12174200-12176400 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
16 | chr5:12174200-12177000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr5:12174400-12174800 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
18 | chr5:12174800-12175600 | Enhancers | HUES48 Cell Line | embryonic stem cell |